Cepharanthin, a multidrug resistant modifier, is a substrate for P- glycoprotein

M. Hirai, K. Tanaka, T. Shimizu, Yusuke Tanigawara, M. Yasuhara, R. Hori, Y. Kakehi, O. Yoshida, K. Ueda, T. Komano, K. I. Inui

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

P-glycoprotein modulators are respected to be multidrug resistance reversing agents in cancer chemotherapy. Some calcium channel blockers, calmodulin inhibitors or immunosuppressive agents have been used in clinical studies, although the dose of these drugs required to test in vitro experimental data might cause potent pharmacological effects which are not desirable in patients. By using LLC-GA5-COL150 cells that express P- glycoprotein specifically on the apical membranes, we examined the transport of anticancer drugs mediated by P-glycoprotein. Cepharanthin, a biscoclaurine alkaloid, potently inhibits the transport of vinblastine and daunorubicin, both commonly used anticancer agents. The 50% inhibitory concentration of cepharanthin on daunorubicin transport was 2.06 μM. Combined inhibitory effects on daunorubicin transport were observed when cepharanthin was used together with cyclosporin A, a potent immunosuppressive agent and P- glycoprotein modulator. Cepharanthin itself was transported by P- glycoprotein. Transcellular transport of cepharanthin across LLC-GA5-COL150 cell monolayers was saturable when its concentration was under 5 μM, and the transport was inhibited by P-glycoprotein modulators. These results indicate that cepharanthin can reverse multidrug resistance, and proper combination with other P-glycoprotein modulators could potentiate its inhibitory effect on expelling the anticancer drugs out of the cell via P-glycoprotein.

Original languageEnglish
Pages (from-to)73-78
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume275
Issue number1
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

P-Glycoprotein
Daunorubicin
Multiple Drug Resistance
Immunosuppressive Agents
Antineoplastic Agents
Pharmaceutical Preparations
Transcytosis
Vinblastine
cepharanthine
Calcium Channel Blockers
Calmodulin
Alkaloids
Cyclosporine
Inhibitory Concentration 50
Pharmacology
Membranes

ASJC Scopus subject areas

  • Pharmacology

Cite this

Hirai, M., Tanaka, K., Shimizu, T., Tanigawara, Y., Yasuhara, M., Hori, R., ... Inui, K. I. (1995). Cepharanthin, a multidrug resistant modifier, is a substrate for P- glycoprotein. Journal of Pharmacology and Experimental Therapeutics, 275(1), 73-78.

Cepharanthin, a multidrug resistant modifier, is a substrate for P- glycoprotein. / Hirai, M.; Tanaka, K.; Shimizu, T.; Tanigawara, Yusuke; Yasuhara, M.; Hori, R.; Kakehi, Y.; Yoshida, O.; Ueda, K.; Komano, T.; Inui, K. I.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 275, No. 1, 1995, p. 73-78.

Research output: Contribution to journalArticle

Hirai, M, Tanaka, K, Shimizu, T, Tanigawara, Y, Yasuhara, M, Hori, R, Kakehi, Y, Yoshida, O, Ueda, K, Komano, T & Inui, KI 1995, 'Cepharanthin, a multidrug resistant modifier, is a substrate for P- glycoprotein', Journal of Pharmacology and Experimental Therapeutics, vol. 275, no. 1, pp. 73-78.
Hirai, M. ; Tanaka, K. ; Shimizu, T. ; Tanigawara, Yusuke ; Yasuhara, M. ; Hori, R. ; Kakehi, Y. ; Yoshida, O. ; Ueda, K. ; Komano, T. ; Inui, K. I. / Cepharanthin, a multidrug resistant modifier, is a substrate for P- glycoprotein. In: Journal of Pharmacology and Experimental Therapeutics. 1995 ; Vol. 275, No. 1. pp. 73-78.
@article{919abb48879d4bc5879f318139a4cc33,
title = "Cepharanthin, a multidrug resistant modifier, is a substrate for P- glycoprotein",
abstract = "P-glycoprotein modulators are respected to be multidrug resistance reversing agents in cancer chemotherapy. Some calcium channel blockers, calmodulin inhibitors or immunosuppressive agents have been used in clinical studies, although the dose of these drugs required to test in vitro experimental data might cause potent pharmacological effects which are not desirable in patients. By using LLC-GA5-COL150 cells that express P- glycoprotein specifically on the apical membranes, we examined the transport of anticancer drugs mediated by P-glycoprotein. Cepharanthin, a biscoclaurine alkaloid, potently inhibits the transport of vinblastine and daunorubicin, both commonly used anticancer agents. The 50{\%} inhibitory concentration of cepharanthin on daunorubicin transport was 2.06 μM. Combined inhibitory effects on daunorubicin transport were observed when cepharanthin was used together with cyclosporin A, a potent immunosuppressive agent and P- glycoprotein modulator. Cepharanthin itself was transported by P- glycoprotein. Transcellular transport of cepharanthin across LLC-GA5-COL150 cell monolayers was saturable when its concentration was under 5 μM, and the transport was inhibited by P-glycoprotein modulators. These results indicate that cepharanthin can reverse multidrug resistance, and proper combination with other P-glycoprotein modulators could potentiate its inhibitory effect on expelling the anticancer drugs out of the cell via P-glycoprotein.",
author = "M. Hirai and K. Tanaka and T. Shimizu and Yusuke Tanigawara and M. Yasuhara and R. Hori and Y. Kakehi and O. Yoshida and K. Ueda and T. Komano and Inui, {K. I.}",
year = "1995",
language = "English",
volume = "275",
pages = "73--78",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Cepharanthin, a multidrug resistant modifier, is a substrate for P- glycoprotein

AU - Hirai, M.

AU - Tanaka, K.

AU - Shimizu, T.

AU - Tanigawara, Yusuke

AU - Yasuhara, M.

AU - Hori, R.

AU - Kakehi, Y.

AU - Yoshida, O.

AU - Ueda, K.

AU - Komano, T.

AU - Inui, K. I.

PY - 1995

Y1 - 1995

N2 - P-glycoprotein modulators are respected to be multidrug resistance reversing agents in cancer chemotherapy. Some calcium channel blockers, calmodulin inhibitors or immunosuppressive agents have been used in clinical studies, although the dose of these drugs required to test in vitro experimental data might cause potent pharmacological effects which are not desirable in patients. By using LLC-GA5-COL150 cells that express P- glycoprotein specifically on the apical membranes, we examined the transport of anticancer drugs mediated by P-glycoprotein. Cepharanthin, a biscoclaurine alkaloid, potently inhibits the transport of vinblastine and daunorubicin, both commonly used anticancer agents. The 50% inhibitory concentration of cepharanthin on daunorubicin transport was 2.06 μM. Combined inhibitory effects on daunorubicin transport were observed when cepharanthin was used together with cyclosporin A, a potent immunosuppressive agent and P- glycoprotein modulator. Cepharanthin itself was transported by P- glycoprotein. Transcellular transport of cepharanthin across LLC-GA5-COL150 cell monolayers was saturable when its concentration was under 5 μM, and the transport was inhibited by P-glycoprotein modulators. These results indicate that cepharanthin can reverse multidrug resistance, and proper combination with other P-glycoprotein modulators could potentiate its inhibitory effect on expelling the anticancer drugs out of the cell via P-glycoprotein.

AB - P-glycoprotein modulators are respected to be multidrug resistance reversing agents in cancer chemotherapy. Some calcium channel blockers, calmodulin inhibitors or immunosuppressive agents have been used in clinical studies, although the dose of these drugs required to test in vitro experimental data might cause potent pharmacological effects which are not desirable in patients. By using LLC-GA5-COL150 cells that express P- glycoprotein specifically on the apical membranes, we examined the transport of anticancer drugs mediated by P-glycoprotein. Cepharanthin, a biscoclaurine alkaloid, potently inhibits the transport of vinblastine and daunorubicin, both commonly used anticancer agents. The 50% inhibitory concentration of cepharanthin on daunorubicin transport was 2.06 μM. Combined inhibitory effects on daunorubicin transport were observed when cepharanthin was used together with cyclosporin A, a potent immunosuppressive agent and P- glycoprotein modulator. Cepharanthin itself was transported by P- glycoprotein. Transcellular transport of cepharanthin across LLC-GA5-COL150 cell monolayers was saturable when its concentration was under 5 μM, and the transport was inhibited by P-glycoprotein modulators. These results indicate that cepharanthin can reverse multidrug resistance, and proper combination with other P-glycoprotein modulators could potentiate its inhibitory effect on expelling the anticancer drugs out of the cell via P-glycoprotein.

UR - http://www.scopus.com/inward/record.url?scp=0028841253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028841253&partnerID=8YFLogxK

M3 - Article

C2 - 7562598

AN - SCOPUS:0028841253

VL - 275

SP - 73

EP - 78

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -